oligodendroglioma
|
disease |
Neoplasms
|
Neoplastic Process
|
8
|
|
0.600 |
None |
1.000 |
8 |
|
2009 |
2019 |
Anaplastic Oligodendroglioma
|
disease |
Neoplasms
|
Neoplastic Process
|
8
|
1
|
0.580 |
None |
0.933 |
8 |
|
2009 |
2019 |
Mixed Oligodendroglioma-Astrocytoma
|
disease |
Neoplasms
|
Neoplastic Process
|
7
|
|
0.510 |
None |
1.000 |
7 |
|
2009 |
2015 |
Anaplastic astrocytoma
|
disease |
Neoplasms
|
Neoplastic Process
|
27
|
2
|
0.400 |
None |
1.000 |
7 |
|
2009 |
2019 |
Anaplastic Oligoastrocytoma
|
disease |
Neoplasms
|
Neoplastic Process
|
1
|
|
0.310 |
None |
1.000 |
6 |
|
2009 |
2014 |
Fibrillary Astrocytoma
|
disease |
Neoplasms
|
Neoplastic Process
|
26
|
|
0.320 |
None |
1.000 |
6 |
|
2009 |
2019 |
Protoplasmic astrocytoma
|
disease |
Neoplasms
|
Neoplastic Process
|
26
|
|
0.300 |
None |
1.000 |
6 |
|
2009 |
2014 |
Gemistocytic astrocytoma
|
disease |
Neoplasms
|
Neoplastic Process
|
26
|
|
0.310 |
None |
1.000 |
6 |
|
2009 |
2014 |
D-2-HYDROXYGLUTARIC ACIDURIA 2
|
disease |
|
Disease or Syndrome
|
1
|
2
|
0.610 |
None |
1.000 |
3 |
2
|
2010 |
2018 |
Peripheral T-Cell Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
10
|
|
0.360 |
None |
1.000 |
2 |
|
2012 |
2019 |
Acute Myeloid Leukemia (AML-M2)
|
disease |
Neoplasms
|
Neoplastic Process
|
125
|
5
|
0.310 |
None |
1.000 |
2 |
|
2012 |
2017 |
Enchondroma
|
disease |
Neoplasms
|
Neoplastic Process
|
2
|
|
0.340 |
None |
1.000 |
2 |
|
2011 |
2019 |
Chondroma
|
disease |
Neoplasms
|
Neoplastic Process
|
2
|
|
0.320 |
None |
1.000 |
2 |
|
2011 |
2016 |
GLIOMA SUSCEPTIBILITY 1
|
phenotype |
|
Finding
|
6
|
14
|
0.300 |
None |
1.000 |
2 |
2
|
2009 |
2015 |
Enchondromatosis
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
4
|
1
|
0.770 |
None |
1.000 |
2 |
|
2011 |
2019 |
Acute Myeloid Leukemia, M1
|
disease |
Neoplasms
|
Neoplastic Process
|
125
|
|
0.310 |
None |
1.000 |
2 |
|
2011 |
2017 |
Maffucci Syndrome
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
3
|
|
0.650 |
None |
1.000 |
2 |
|
2011 |
2016 |
Leukemia, Myelocytic, Acute
|
disease |
Neoplasms
|
Neoplastic Process
|
173
|
6669
|
0.700 |
None |
0.961 |
2 |
5
|
2010 |
2019 |
Dyschondroplasias
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases
|
Congenital Abnormality
|
19
|
|
0.300 |
None |
1.000 |
2 |
|
2011 |
2011 |
Seizures, Auditory
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Pathologic Function
|
101
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Olfactory seizure
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
101
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Atonic Absence Seizures
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
101
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Gustatory seizure
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
101
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Single Seizure
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
101
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Non-epileptic convulsion
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
101
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |